Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
Bartosz Gąsiorkiewicz, Paulina Koczurkiewicz, Kamil Piska, et al.
Investigational New Drugs (2020) Vol. 39, Iss. 2, pp. 538-563
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 149
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 118
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Aleksandra Zoń, Ilona Bednarek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7585-7585
Open Access | Times Cited: 65
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 95
Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms
Jinhui Guo, Jie Zhao, Wen Fu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Is Autophagy Always a Barrier to Cisplatin Therapy?
Jingwen Xu, David A. Gewirtz
Biomolecules (2022) Vol. 12, Iss. 3, pp. 463-463
Open Access | Times Cited: 43
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Rui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 24
Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
Mobina Bayat, Javid Sadri Nahand
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 9
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats
Amal Al-Shahat, Mohey Hulail, Nada M. M. Soliman, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2769-2769
Open Access | Times Cited: 35
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
Chun‐Liang Chen, Yu‐Cheng Lin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10055-10055
Open Access | Times Cited: 29
The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer
Ryan Finnegan, Ahmed M. Elshazly, Nipa Patel, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 19
Cisplatin ototoxicity mechanism and antagonistic intervention strategy: a scope review
Yingru Li, Tianyang Zhang, Qiang Song, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 18
Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells
Reziyamu Wufuer, Keli Liu, Jing Feng, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 488-511
Closed Access | Times Cited: 7
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
Wentao Mu, Zhi Yao, Jianpeng Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma
Su Young Oh, Jin‐Kyung Kim, Kah Young Lee, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 5
Exploring Arylidene–Indolinone Ligands of Autophagy Proteins LC3B and GABARAP
Alexandria N. Leveille, Thomas Schwarzrock, Hawley Brown, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 2, pp. 271-277
Open Access
Impaired Autophagic Flux by Citalopram Inhibits DR5 Degradation and Increases TRAIL‐Mediated Apoptosis
Kazi Md. Ali Zinnah, Ali Newaz Munna, Jae‐Won Seol, et al.
Journal of Clinical Pharmacy and Therapeutics (2025) Vol. 2025, Iss. 1
Open Access
Lysosomes and LAMPs as Autophagy Drivers of Drug Resistance in Colorectal Cancer
Tsvetomira Ivanova, Yordan Sbirkov, Maria Kazakova, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 574-574
Open Access
LAPTM5 confers cisplatin resistance in NSCLC by suppressing LAMP1 ubiquitination to stabilize lysosomal membranes and sustain autophagic flux
Fan Wu, Chunlan Li, Xianrang Song, et al.
Cellular Signalling (2025), pp. 111834-111834
Closed Access
Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine
Aleksandra Olszewska, Agata Borkowska, Monika Granica, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 17
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
Lena Berning, David Schlütermann, Annabelle Friedrich, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1294-1294
Open Access | Times Cited: 19
Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA
Ke Yao, Xiaoying Chen, Yuting Su, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin
Asadollah Abbasi, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh
Life Sciences (2022) Vol. 307, pp. 120884-120884
Closed Access | Times Cited: 13
Phytol and α-Bisabolol Synergy Induces Autophagy and Apoptosis in A549 Cells and Additional Molecular Insights through Comprehensive Proteome Analysis via Nano LC-MS/MS
Chandramohan Kiruthiga, Kambati Niharika, Kasi Pandima Devi
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 10, pp. 773-788
Closed Access | Times Cited: 2
Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline
Kazi Md. Ali Zinnah, Sang‐Youel Park
Oncology Reports (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top